The Normal anticoagulant system and risk of placental abruption: protein C, protein S and resistance to activated protein C

References

• Paidas MJ, Ku DH, Arkel YS. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clin Perinatol 2004;31:783–805, vii.
   PubMedGoogle Scholar
• Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res 2003;109:73–81.
   PubMed Web of Science ®Google Scholar
• Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986;68:881–885.
   PubMed Web of Science ®Google Scholar
• Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CR. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995;90:725–727.
   PubMed Web of Science ®Google Scholar
• Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol 1997;11:403–430.
   PubMed Web of Science ®Google Scholar
• Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance – United States, 1991–1999. MMWR Surveill Summ 2003;52:1–8.
   PubMedGoogle Scholar
• Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166–1170.
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Mousa HA, Martlew V, Briscoe L, Perez-Casal M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001;97(5 Pt 1):753–759.
   PubMedGoogle Scholar
• Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000;96:45–49.
   PubMed Web of Science ®Google Scholar
• Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daures JP, Mares P. Case–control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent – the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 1999;81:891–899.
   PubMed Web of Science ®Google Scholar
• Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kupferminc MJ. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002;99(5 Pt 1):684–687.
   PubMedGoogle Scholar
• Zdoukopoulos N, Zintzaras E. Genetic risk factors for placental abruption: a HuGE review and meta-analysis. Epidemiology 2008;19:309–323.
   PubMedGoogle Scholar
• Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W, et al Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913–916.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Elsasser DA, Kinzler WL, Peltier MR, Getahun D, Leclerc D, Rozen RR. Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption. Mol Genet Metab 2007;91:104–110.
   PubMedGoogle Scholar
• Ananth CV, Peltier MR, De Marco C, Elsasser DA, Getahun D, Rozen R, Smulian JC. Associations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption. Am J Obstet Gynecol 2007;197:385.e1–385.e7.
   Google Scholar
• Ananth CV, Peltier MR, Moore DF, Kinzler WL, Leclerc D, Rozen RR. Reduced folate carrier 80A – >G polymorphism, plasma folate, and risk of placental abruption. Hum Genet 2008;124:137–145.
   PubMed Web of Science ®Google Scholar
• Elsasser DA, Ananth CV, Prasad V, Vintzileos AM; New Jersey-Placental Abruption Study Investigators. Diagnosis of placental abruption: relationship between clinical and histopathological findings. Eur J Obstet Gynecol Reprod Biol 2010;148:125–130.
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101:6–14.
   PubMed Web of Science ®Google Scholar
• Rotmensch S, Liberati M, Mittlemann M, Ben-Rafael Z. Activated protein C resistance and adverse pregnancy outcome. Am J Obstet Gynecol 1997;177:170–173.
   PubMedGoogle Scholar
• Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, Shalev E. Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol 1998;179(6 Pt 1):1565–1567.
   PubMedGoogle Scholar
• Redline RW. Thrombophilia and placental pathology. Clin Obstet Gynecol 2006;49:885–894.
   PubMed Web of Science ®Google Scholar
• Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, Mackman N, Weiler H. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 2003;9:331–337.
   PubMed Web of Science ®Google Scholar
• Sadler JE. Thrombomodulin structure and function. Thromb Haemost 1997;78:392–395.
   PubMed Web of Science ®Google Scholar
• Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 2001;97:1685–1688.
   PubMed Web of Science ®Google Scholar
• Franchi F, Biguzzi E, Cetin I, Facchetti F, Radaelli T, Bozzo M, Pardi G, Faioni EM. Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Br J Haematol 2001;114:641–646.
   PubMed Web of Science ®Google Scholar
• Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 1985;101:363–371.
   PubMed Web of Science ®Google Scholar
• Spek CA, Koster T, Rosendaal FR, Bertina RM, Reitsma PH. Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 1995;15:214–218.
   PubMed Web of Science ®Google Scholar
• Buil A, Soria JM, Souto JC, Almasy L, Lathrop M, Blangero J, Fontcuberta J. Protein C levels are regulated by a quantitative trait locus on chromosome 16: results from the Genetic Analysis of Idiopathic thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biol 2004;24:1321–1325.
   PubMedGoogle Scholar